Put yourself in the position of the FDA. Having convinced themselves of the accuracy and potential of the app, I have an idea they wont want to rush into approving it for sale to mums and dads, no matter how accurate it is. I think they would want to see it in the hands of health professionals.
Health professionals are able to assess the whole history and life situation and condition of the patient, not just the cough; and then, giving due weight to the Resapp analysis, make a balanced diagnosis and prescription.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Provides Updated Paediatric Clinical Study Results
Ann: ResApp Provides Updated Paediatric Clinical Study Results, page-112
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online